APUR THYROID Trademark

Trademark Overview

On Sunday, December 5, 2021, a trademark application was filed for APUR THYROID with the United States Patent and Trademark Office. The USPTO has given the APUR THYROID trademark a serial number of 97156558. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, June 6, 2024. This trademark is owned by Vitruvias Therapeutics Inc.. The APUR THYROID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of thyroid disease
apur thyroid

General Information

Serial Number97156558
Word MarkAPUR THYROID
Filing DateSunday, December 5, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, June 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of thyroid disease
NOT AVAILABLE"THYROID"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVitruvias Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAuburn, AL 36830
Party NameVitruvias Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAuburn, AL 36830

Trademark Events

Event DateEvent Description
Wednesday, December 8, 2021NEW APPLICATION ENTERED
Wednesday, December 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 13, 2022ASSIGNED TO EXAMINER
Friday, September 16, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, September 16, 2022EXAMINERS AMENDMENT E-MAILED
Friday, September 16, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 16, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, September 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, June 25, 2023SOU TEAS EXTENSION RECEIVED
Sunday, June 25, 2023SOU EXTENSION 1 FILED
Sunday, June 25, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 12, 2023SOU EXTENSION 2 FILED
Tuesday, December 12, 2023SOU EXTENSION 2 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 6, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 6, 2024SOU EXTENSION 3 GRANTED
Thursday, June 6, 2024SOU EXTENSION 3 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

thyroid apur disease treatment preparations pharmaceutical